876593-45-2Relevant academic research and scientific papers
Conformationally biased P3 amide replacements of β-secretase inhibitors
Stachel, Shawn J.,Coburn, Craig A.,Steele, Thomas G.,Crouthamel, Min-Chi,Pietrak, Beth L.,Lai, Ming-Tain,Holloway, M. Katharine,Munshi, Sanjeev K.,Graham, Samuel L.,Vacca, Joseph P.
, p. 641 - 644 (2007/10/03)
We have synthesized and evaluated a series of conformationally biased P3 amide replacements based on an isophthalamide lead structure. The studies resulted in the identification of the β-secretase inhibitor 7m which has an in vitro IC50 = 35 nM
PHENYLCARBOXAMIDE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
Page 53, (2008/06/13)
The present invention is directed to compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment or prevention of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is a
